ERCC1 and head and neck squamous cell carcinoma: Two larger retrospective trials showed prognostic benefit of low ERCC1 expression in HNSCC (HR 0.42, CI95% 0.20–0.90, P 0.03 and HR 0.12, P 0.043) [148, 149].